As XIST represented as a potent oncogene in colorectal cancer (CRC), our team presumed that m6A might regulate biological behavior of CRC cells through modifying XIST. As expected, we found that XIST was targeted by METTL14 instead of METTL3 in CRC cells. The gene discussed is XIST; the disease is colorectal cancer.